CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 155 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,174,940 | -13.1% | 180,343 | -1.6% | 0.01% | -12.5% |
| Q4 2022 | $4,803,587 | +28.2% | 183,343 | -3.8% | 0.01% | +14.3% |
| Q3 2022 | $3,746,000 | +579.9% | 190,543 | +465.8% | 0.01% | +600.0% |
| Q1 2022 | $551,000 | +5.4% | 33,674 | +4.9% | 0.00% | 0.0% |
| Q4 2021 | $523,000 | – | 32,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |